Effects of intraperitoneal heparin on peritoneal transport in a chronic animal model of peritoneal dialysis

Krzysztof Pawlaczyk, Malgorzata Kuzlan-Pawlaczyk, Björn Anderstam, Olof Heimbürger, Jonas Bergström, Jacek Waniewski, Andrzej Breborowicz, Bengt Lindholm

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background. Heparin has anti-inflammatory effects and is often added to the peritoneal dialysis fluid to prevent fibrin formation. Conjugation of heparin to the surface of biomaterials has been shown to improve its biocompatibility. In this study, we describe for the first time an experimental chronic peritoneal dialysis model with repeated dwell studies in non-uraemic rats and evaluate the effect of addition of heparin to glucose-based peritoneal dialysis fluid on peritoneal fluid and solute transport. Methods. Wistar male rats, weighing 340±15 g, with implanted peritoneal catheters were infused during 1 month, twice per day with 20 ml of Dianeal 1.36%+antibiotics (AB; n=10) or Dianeal 1.36%+antibiotics+heparin 2500 U/I (HAB; n=9). After 10 (DS 1) and 30 days (DS 2), a dwell study was performed in rats with free access to drinking water, by infusing 30 ml of Dianeal 3.86%. Dialysate samples were obtained at 0, 2, 30, 60, 120 and 240 min. Blood samples were drawn before and at the end of the dwell. Radiolabelled serum albumin was used as macromolecular volume marker. Results. Peritoneal volumes during DS 1 were significantly greater for the HAB group as compared with the AB group. No differences in ultrafiltration were found during DS 2 for HAB vs AB. However, peritoneal volumes were significantly higher for DS 2 compared with DS 1 in the AB group. The amount of glucose absorbed over time did not differ between the solutions, while fluid absorption tended to be lower in the HAB group. Conclusions. Heparin may improve peritoneal fluid transport possibly due to better healing and reduced peritoneal inflammation as shown in this novel animal model of chronic peritoneal dialysis with repeated dwell studies.

Original languageEnglish (US)
Pages (from-to)669-671
Number of pages3
JournalNephrology Dialysis Transplantation
Volume16
Issue number3
StatePublished - 2001
Externally publishedYes

Fingerprint

Peritoneal Dialysis
Ascitic Fluid
Heparin
Animal Models
Anti-Bacterial Agents
Glucose
Dialysis Solutions
Ultrafiltration
Biocompatible Materials
Fibrin
Serum Albumin
Drinking Water
Wistar Rats
Anti-Inflammatory Agents
Catheters
Inflammation

Keywords

  • Animal model
  • Chronic peritoneal dialysis
  • Heparin
  • Peritoneal transport
  • Repeated dwell studies
  • Ultrafiltration

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

Pawlaczyk, K., Kuzlan-Pawlaczyk, M., Anderstam, B., Heimbürger, O., Bergström, J., Waniewski, J., ... Lindholm, B. (2001). Effects of intraperitoneal heparin on peritoneal transport in a chronic animal model of peritoneal dialysis. Nephrology Dialysis Transplantation, 16(3), 669-671.

Effects of intraperitoneal heparin on peritoneal transport in a chronic animal model of peritoneal dialysis. / Pawlaczyk, Krzysztof; Kuzlan-Pawlaczyk, Malgorzata; Anderstam, Björn; Heimbürger, Olof; Bergström, Jonas; Waniewski, Jacek; Breborowicz, Andrzej; Lindholm, Bengt.

In: Nephrology Dialysis Transplantation, Vol. 16, No. 3, 2001, p. 669-671.

Research output: Contribution to journalArticle

Pawlaczyk, K, Kuzlan-Pawlaczyk, M, Anderstam, B, Heimbürger, O, Bergström, J, Waniewski, J, Breborowicz, A & Lindholm, B 2001, 'Effects of intraperitoneal heparin on peritoneal transport in a chronic animal model of peritoneal dialysis', Nephrology Dialysis Transplantation, vol. 16, no. 3, pp. 669-671.
Pawlaczyk K, Kuzlan-Pawlaczyk M, Anderstam B, Heimbürger O, Bergström J, Waniewski J et al. Effects of intraperitoneal heparin on peritoneal transport in a chronic animal model of peritoneal dialysis. Nephrology Dialysis Transplantation. 2001;16(3):669-671.
Pawlaczyk, Krzysztof ; Kuzlan-Pawlaczyk, Malgorzata ; Anderstam, Björn ; Heimbürger, Olof ; Bergström, Jonas ; Waniewski, Jacek ; Breborowicz, Andrzej ; Lindholm, Bengt. / Effects of intraperitoneal heparin on peritoneal transport in a chronic animal model of peritoneal dialysis. In: Nephrology Dialysis Transplantation. 2001 ; Vol. 16, No. 3. pp. 669-671.
@article{60167b15d45f4294a02df61f38b6e240,
title = "Effects of intraperitoneal heparin on peritoneal transport in a chronic animal model of peritoneal dialysis",
abstract = "Background. Heparin has anti-inflammatory effects and is often added to the peritoneal dialysis fluid to prevent fibrin formation. Conjugation of heparin to the surface of biomaterials has been shown to improve its biocompatibility. In this study, we describe for the first time an experimental chronic peritoneal dialysis model with repeated dwell studies in non-uraemic rats and evaluate the effect of addition of heparin to glucose-based peritoneal dialysis fluid on peritoneal fluid and solute transport. Methods. Wistar male rats, weighing 340±15 g, with implanted peritoneal catheters were infused during 1 month, twice per day with 20 ml of Dianeal 1.36{\%}+antibiotics (AB; n=10) or Dianeal 1.36{\%}+antibiotics+heparin 2500 U/I (HAB; n=9). After 10 (DS 1) and 30 days (DS 2), a dwell study was performed in rats with free access to drinking water, by infusing 30 ml of Dianeal 3.86{\%}. Dialysate samples were obtained at 0, 2, 30, 60, 120 and 240 min. Blood samples were drawn before and at the end of the dwell. Radiolabelled serum albumin was used as macromolecular volume marker. Results. Peritoneal volumes during DS 1 were significantly greater for the HAB group as compared with the AB group. No differences in ultrafiltration were found during DS 2 for HAB vs AB. However, peritoneal volumes were significantly higher for DS 2 compared with DS 1 in the AB group. The amount of glucose absorbed over time did not differ between the solutions, while fluid absorption tended to be lower in the HAB group. Conclusions. Heparin may improve peritoneal fluid transport possibly due to better healing and reduced peritoneal inflammation as shown in this novel animal model of chronic peritoneal dialysis with repeated dwell studies.",
keywords = "Animal model, Chronic peritoneal dialysis, Heparin, Peritoneal transport, Repeated dwell studies, Ultrafiltration",
author = "Krzysztof Pawlaczyk and Malgorzata Kuzlan-Pawlaczyk and Bj{\"o}rn Anderstam and Olof Heimb{\"u}rger and Jonas Bergstr{\"o}m and Jacek Waniewski and Andrzej Breborowicz and Bengt Lindholm",
year = "2001",
language = "English (US)",
volume = "16",
pages = "669--671",
journal = "Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Effects of intraperitoneal heparin on peritoneal transport in a chronic animal model of peritoneal dialysis

AU - Pawlaczyk, Krzysztof

AU - Kuzlan-Pawlaczyk, Malgorzata

AU - Anderstam, Björn

AU - Heimbürger, Olof

AU - Bergström, Jonas

AU - Waniewski, Jacek

AU - Breborowicz, Andrzej

AU - Lindholm, Bengt

PY - 2001

Y1 - 2001

N2 - Background. Heparin has anti-inflammatory effects and is often added to the peritoneal dialysis fluid to prevent fibrin formation. Conjugation of heparin to the surface of biomaterials has been shown to improve its biocompatibility. In this study, we describe for the first time an experimental chronic peritoneal dialysis model with repeated dwell studies in non-uraemic rats and evaluate the effect of addition of heparin to glucose-based peritoneal dialysis fluid on peritoneal fluid and solute transport. Methods. Wistar male rats, weighing 340±15 g, with implanted peritoneal catheters were infused during 1 month, twice per day with 20 ml of Dianeal 1.36%+antibiotics (AB; n=10) or Dianeal 1.36%+antibiotics+heparin 2500 U/I (HAB; n=9). After 10 (DS 1) and 30 days (DS 2), a dwell study was performed in rats with free access to drinking water, by infusing 30 ml of Dianeal 3.86%. Dialysate samples were obtained at 0, 2, 30, 60, 120 and 240 min. Blood samples were drawn before and at the end of the dwell. Radiolabelled serum albumin was used as macromolecular volume marker. Results. Peritoneal volumes during DS 1 were significantly greater for the HAB group as compared with the AB group. No differences in ultrafiltration were found during DS 2 for HAB vs AB. However, peritoneal volumes were significantly higher for DS 2 compared with DS 1 in the AB group. The amount of glucose absorbed over time did not differ between the solutions, while fluid absorption tended to be lower in the HAB group. Conclusions. Heparin may improve peritoneal fluid transport possibly due to better healing and reduced peritoneal inflammation as shown in this novel animal model of chronic peritoneal dialysis with repeated dwell studies.

AB - Background. Heparin has anti-inflammatory effects and is often added to the peritoneal dialysis fluid to prevent fibrin formation. Conjugation of heparin to the surface of biomaterials has been shown to improve its biocompatibility. In this study, we describe for the first time an experimental chronic peritoneal dialysis model with repeated dwell studies in non-uraemic rats and evaluate the effect of addition of heparin to glucose-based peritoneal dialysis fluid on peritoneal fluid and solute transport. Methods. Wistar male rats, weighing 340±15 g, with implanted peritoneal catheters were infused during 1 month, twice per day with 20 ml of Dianeal 1.36%+antibiotics (AB; n=10) or Dianeal 1.36%+antibiotics+heparin 2500 U/I (HAB; n=9). After 10 (DS 1) and 30 days (DS 2), a dwell study was performed in rats with free access to drinking water, by infusing 30 ml of Dianeal 3.86%. Dialysate samples were obtained at 0, 2, 30, 60, 120 and 240 min. Blood samples were drawn before and at the end of the dwell. Radiolabelled serum albumin was used as macromolecular volume marker. Results. Peritoneal volumes during DS 1 were significantly greater for the HAB group as compared with the AB group. No differences in ultrafiltration were found during DS 2 for HAB vs AB. However, peritoneal volumes were significantly higher for DS 2 compared with DS 1 in the AB group. The amount of glucose absorbed over time did not differ between the solutions, while fluid absorption tended to be lower in the HAB group. Conclusions. Heparin may improve peritoneal fluid transport possibly due to better healing and reduced peritoneal inflammation as shown in this novel animal model of chronic peritoneal dialysis with repeated dwell studies.

KW - Animal model

KW - Chronic peritoneal dialysis

KW - Heparin

KW - Peritoneal transport

KW - Repeated dwell studies

KW - Ultrafiltration

UR - http://www.scopus.com/inward/record.url?scp=0035090217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035090217&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 669

EP - 671

JO - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

JF - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

SN - 0931-0509

IS - 3

ER -